mail
versión imprimible
 
 

2nd LNP Characterization and Analytical Development Summit

Evvnt Promotion / evvnt
Archivo
-
06.11.2024 - 08.11.2024  W Boston, 100 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 3:30 PM
 
Temas de la conferencia
Turbocharged by increased LNP pipeline development and technological advancements with SPARTA biodiscovery raising $4.3m for their characterization technology, UPENN engineers developing CAR-T therapies, and Genevant securing a $114m deal with Tome. As the industry places a greater emphasis on later-phase assets, understanding the intricacies of LNPs and investing in analytical assays are becoming essential for ensuring market confidence.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2555692-3?pid=4832

Speakers: Benjamin Hall, Senior Scientist - Analytical Development, Tessera Therapeutics, Carlo Zambonelli PhD, Independent Expert, and more
 

Información e inscripción:

https://go.evvnt.com/2555692-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference Only - Drug Developer: USD 2999.00, Conference Only - Solution Provider: USD 3699.00, Conference Only - Academics: USD 2599.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Ärzte der WeltnewTreeAlumni Club Medizinische Universität WienÖsterreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.AGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für Wien